Arkolith/Insider Trading/TMDX/Form 4

Gunderson Thomas J.

DirectorTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$722K
Net Open-Market Flow
-$722K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)19K$2.21$43K26K
Jun 15, 2026Sell(S)10K$75.06$722K17K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)19K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-274178) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML